Search Results

Researchers found that damage to the brain’s white matter after COVID-19 resembles that seen after cancer chemotherapy, raising hope for treatments to help both conditions.

Researchers have identified a mechanism underlying fragmented sleep with older age, paving the way for potential drug therapies.

Using machine learning, Stanford Medicine scientists and their colleagues have found hundreds of genes that could play a role in amyotrophic lateral sclerosis.

The neuroscientist and pediatric neuro-oncologist is being recognized for her work to understand healthy brain development and create therapies for a group of lethal brain tumors.

Scientists have identified a key factor in mental aging and shown that it might be prevented or reversed by fixing a glitch in the immune system’s front-line soldiers.

Annelise Barron, Peter Kim, Siddhartha Jaiswal and Keren Haroush will receive grants totaling $10 million to fund their investigations. The awards support risky efforts that could potentially have a big impact in the biomedical sciences.

A common genetic deletion boosts the risk for schizophrenia by 30-fold. Generating nerve cells from people with the deletion has showed Stanford researchers why.

The researchers also identified a molecular pathway involved in turning back the clock on the cells. Drugs that could manipulate the pathway might be an effective substitute for exercise, they suggest.

A drug may help children with Pelizaeus-Merzbacher disease, a deadly neurological disorder, according to a study by researchers at Stanford, UCSF and Cambridge.

Stanford researchers blocked a molecule to help restore neurons in rats in which the flow of fresh blood to the brain was reduced. The approach could lead to new treatments for people who have suffered a stroke or cardiac arrest.